Glucosa Y Cloruro De Sodio, Viaflo Baxter

Glucosa Y Cloruro De Sodio, marketed as Viaflo Baxter, is an injectable solution that combines sodium chloride and glucose in a sterile aqueous vehicle. The product is supplied in a ready‑to‑use vial for intravenous administration and is intended for use in the European Union. It provides both electrolytes and carbohydrate energy to support fluid balance and metabolic needs. The solution is isotonic and designed for rapid infusion in clinical settings.

Viaflo Baxter is indicated for several clinical situations where fluid, electrolyte, and energy replacement are required.

- Fluid and electrolyte replacement in patients with dehydration or losses from surgery, trauma, or gastrointestinal disorders. - Treatment of hypoglycemia when rapid glucose delivery is needed. - Component of parenteral nutrition regimens to provide carbohydrate calories. - Support during diagnostic or therapeutic procedures that require intravenous fluid administration. - Maintenance of plasma volume in perioperative care.

Adverse reactions to Glucosa Y Cloruro De Sodio are generally related to the infusion itself or to the individual components.

Common: - Mild local irritation or pain at the injection site. - Transient increase in blood glucose levels. - Electrolyte shifts causing mild hypernatremia or hyponatremia. - Nausea or vomiting related to rapid infusion.

Serious: - Severe hyperglycemia in patients with uncontrolled diabetes. - Fluid overload leading to pulmonary edema. - Allergic reaction such as urticaria, bronchospasm, or anaphylaxis.

Clinicians should evaluate patient-specific factors before administering Glucosa Y Cloruro De Sodio to minimize risks.

- Assess baseline electrolyte levels and glucose concentration, especially in patients with renal or cardiac disease. - Adjust infusion rate in individuals at risk for fluid overload or pulmonary edema. - Use caution in patients with known hypersensitivity to sodium chloride or glucose solutions. - Monitor blood glucose closely in diabetic patients or those receiving concurrent dextrose-containing therapies. - Avoid rapid bolus administration unless clinically indicated. - Consider compatibility with other IV medications; incompatibility may cause precipitation. - Verify correct vial integrity and expiration date before use.

Glucosa Y Cloruro De Sodio may interact with other intravenous agents, affecting safety or efficacy.

Avoid: - Co‑administration with hypertonic saline solutions that could exacerbate hypernatremia. - Simultaneous infusion of calcium‑containing solutions that may precipitate with phosphate additives.

Use with caution: - Concurrent dextrose‑containing medications, which can increase risk of hyperglycemia. - Diuretic therapy, which may alter electrolyte balance during infusion. - Blood products, requiring separate line or flushing to prevent incompatibility.